Homocysteine Lowering and Cognition in CKD: The VA Homocysteine Study

BACKGROUND: Individuals with advanced chronic kidney disease (CKD) and end stage renal disease (ESRD) have high total plasma homocysteine (tHcy) levels, which may be a risk factor for cognitive impairment. Whether treatment with high dose B-vitamins to reduce high tHcy levels improves cognition in p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Brady, Christopher B., Gaziano, J. Michael, Cxypoliski, Roberta A., Guarino, Peter D., Kaufman, James S., Warren, Stuart R., Hartigan, Pamela, Goldfarb, David S., Jamison, Rex L.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2748786/
https://ncbi.nlm.nih.gov/pubmed/19628319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2009.05.013
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items